Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas.

AIM Gastrointestinal stromal tumors (GISTs) are rare. GISTs differ from other mesenchymal tumors of the gastrointestinal tract (e.g. leiomyomas and schwannomas). The purpose of this study was to investigate the role of Ets-1 in the growth and differentiation of GISTs. METHODS Twenty-eight GISTs, nine leiomyomas and six schwannomas were examined by immunohistochemical staining method for Ets-1 in this study. Specimens were selected from surgical pathology archival tissues at Nagasaki University Hospital. RESULTS Ets-1 protein was expressed in the cytoplasm of cells in all of these tumors. Immunohistochemical staining revealed that 27 GISTs (96.4%), six leiomyomas (66.7%), and five schwannomas (83.3%) were positive for Ets-1. Ets-1 expression was statistically different between GISTs and leiomyomas (P<0.005). However, there was no correlation between Ets-1 expression and clinical risk categories. CONCLUSION Ets-1 plays an important role in the growth and differentiation of GISTs, leiomyomas and schwannomas.

[1]  T. Nakayama,et al.  Expressions of parathyroid hormone‐related protein (PTHrP) and PTH/PTHrP‐receptor (PTH/PTHrP‐R) in gastrointestinal stromal tumours (GISTs), leiomyomas and schwannomas , 2004, Scandinavian journal of gastroenterology.

[2]  B. Eisenberg.  Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors. , 2003, Oncology.

[3]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[4]  D. Tuveson,et al.  Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. , 2001, The New England journal of medicine.

[5]  V. Sementchenko,et al.  Ets target genes: past, present and future , 2000, Oncogene.

[6]  L. Sobin,et al.  Gastrointestinal Stromal Tumors and Leiomyosarcomas in the Colon: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 44 Cases , 2000, The American journal of surgical pathology.

[7]  E. van den Berg,et al.  Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  L. Sobin,et al.  Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. , 2000, The American journal of surgical pathology.

[9]  J. Lasota,et al.  Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis , 2000, Virchows Archiv.

[10]  S. Shibata,et al.  Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[11]  K. Chorneyko,et al.  Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. , 1999, The American journal of surgical pathology.

[12]  I. Sekine,et al.  Expression of the ets-1 proto-oncogene in human thyroid tumor. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[13]  M. van Glabbeke,et al.  Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Kovatich,et al.  CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  L. Kindblom,et al.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. , 1998, The American journal of pathology.

[16]  T. Nakayama,et al.  Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[17]  J. Fagin,et al.  Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. , 1998, American journal of physiology. Cell physiology.

[18]  J. Fagin,et al.  Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. , 1996, The American journal of pathology.

[19]  K. Sanders.  A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. , 1996, Gastroenterology.

[20]  M. Miettinen,et al.  Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. , 1995, The American journal of surgical pathology.

[21]  R. Fisher,et al.  ets-1 in astrocytes: expression and transmitter-evoked phosphorylation , 1995, Molecular and cellular biology.

[22]  B. Vandenbunder,et al.  Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. , 1994, Cancer research.

[23]  J. Brady,et al.  Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through an inverted CACCC motif and regulates promoter activity in cooperation with Ets1. , 1994, The Journal of biological chemistry.

[24]  A. Gutierrez-Hartmann,et al.  Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression , 1994, Molecular and cellular biology.

[25]  M. Tymms,et al.  The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Enjoji,et al.  A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors , 1992, Cancer.

[27]  B. Lewin.  Oncogenic conversion by regulatory changes in transcription factors , 1991, Cell.

[28]  Appelman Hd.  Mesenchymal tumors of the gut: historical perspectives, new approaches, new results, and does it make any difference? , 1990 .

[29]  B. Vandenbunder,et al.  Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. , 1989, Development.

[30]  D. Leprince,et al.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26 , 1983, Nature.

[31]  G. Farr,et al.  Myosarcomas of the stomach: Natural history, prognostic factors and management , 1982, Cancer.

[32]  R. Kempson,et al.  Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. A pathologic analysis of 100 cases , 1977, Cancer.